Ethris shares positive data with mRNA drug following new funding

ETH47 is a type III interferon-encoding mRNA drug that could be used to treat respiratory diseases including uncontrolled asthma.

Jun 26, 2024 - 04:00

Ethris shares positive data with mRNA drug following new funding

ETH47 is a type III interferon-encoding mRNA drug that could be used to treat respiratory diseases including uncontrolled asthma.

Read the original article

Tags:

Previous Article

Pharma packaging solutions, design and companies

Merck KGaA abandons Phase III trial for $1.08bn head & neck cancer drug

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

TLM-101 by Therillume for Neurofibromatoses Type I (Von...

Nov 6, 2023

FDA grants RMAT designation to Taysha’s Rett syndrome gene therapy

FDA grants RMAT designation to Taysha’s Rett syndrome g...

May 5, 2024

STAT+: ‘It was my call’: Stanford president defends decision not to correct key paper in misconduct investigation

STAT+: ‘It was my call’: Stanford president defends dec...

Apr 11, 2023